NeuroSense Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. 

CEO
Alon Ben-Noon
CEOAlon Ben-Noon
Employees
15
Employees15
Headquarters
Herzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded
2017
Founded2017
Employees
15
Employees15

NRSN Key Statistics

Market cap
29.22M
Market cap29.22M
Price-Earnings ratio
-2.08
Price-Earnings ratio-2.08
Dividend yield
—
Dividend yield—
Average volume
198.18K
Average volume198.18K
High today
$1.38
High today$1.38
Low today
$1.18
Low today$1.18
Open price
$1.34
Open price$1.34
Volume
245.72K
Volume245.72K
52 Week high
$1.50
52 Week high$1.50
52 Week low
$0.512
52 Week low$0.512

People also own

Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.
Mullen Automotive
Plug Power
Lucid Group
AMC Entertainment
Ocugen, Inc
Tilray Brands
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.